| Original language | English (US) |
|---|---|
| Pages (from-to) | 109-121 |
| Journal | Cancer Translational Medicine |
| Volume | 3 |
| Issue number | 4 |
| State | Published - 2017 |
SKI-178: A multitargeted inhibitor of sphingosine kinase and microtubule dynamics demonstrating therapeutic efficacy in acute myeloid leukemia models
Jeremy Hengst, Taryn E. Dick, Arati Sharma, Kenichiro Doi, Shailaja Hegde, Su Fern Tan, Laura Geffert, Todd E. Fox, Arun K. Sharma, Dhimant Desai, Shantu Amin, Mark Kester, Thomas P. Loughran, Robert Paulson, David Claxton, Hong-Gang Wang, Jong Yun
- Penn State Cancer Institute
- Cancer Institute, Next-Generation Therapies
- Cancer Institute, Mechanisms of Carcinogenesis
- Huck Institutes of the Life Sciences
- Veterinary and Biomedical Sciences
- Department of Medicine
- Department of Pediatrics
- Division of Hematology and Oncology
- Division of Hematology and Oncology
- Center for Cannabis and Natural Product Pharmaceuticals (CCNPP)
- Penn State Neuroscience Institute
- Department of Molecular and Precision Medicine
- Department of Cell and Biological Systems
- Department of Neuroscience and Experimental Therapeutics
Research output: Contribution to journal › Article › peer-review